Anixa biosciences chairman and ceo discusses pioneering car-t cell therapy and breast cancer vaccine in alpha wolf trading interview

San jose, calif. , feb. 14, 2025 /prnewswire/ -- anixa biosciences, inc. ("anixa" or the "company") (nasdaq: anix), a biotechnology company focused on the treatment and prevention of cancer, today announced that its chairman and ceo, dr. amit kumar, was featured in an interview with alpha wolf trading.
CAR Ratings Summary
CAR Quant Ranking